Trump Trade: Should You Buy the Biotech Dips?
Michael King, senior analyst at JMP Securities, examines the sharp decline in biotech stocks in response to criticism on drug pricing from President-elect Donald Trump. He speaks on "Bloomberg Daybreak: Americas." (Source: Bloomberg)
Most Recent Videos
What Waning Gains in Small Caps Signal About the Market
46:02 - Matt Maley, Miller Tabak equity strategist, discusses the outlook for U.S. stocks with Bloomberg's Julie Hyman and Abigail Doolittle on "What'd You Miss?" (Source: Bloomberg)